Clinical Trial

Functional Impact of Acute Respiratory Viral Infections in Older Adults

Study acronym: AFIRI
Recruiting
View on ClinicalTrials.gov →
Summary
The prevention of infectious diseases in older adults remains a major public health challenge, as acute respiratory infections are a leading cause of hospitalisation, mortality, and functional decline worldwide. Immunosenescence and environmental exposures increase susceptibility to infection and reduce vaccine effectiveness in this population. Respiratory viruses, including influenza, SARS-CoV-2, respiratory syncytial virus, and human metapneumovirus, account for a substantial share of this burden, much of which is vaccine-preventable. However, their impact on functional decline and recovery in older adults remains insufficiently characterized. This international study aims to assess the effect of hospitalization for major respiratory viral infections on loss of autonomy in individuals aged 60 years and older, to inform targeted prevention and vaccination strategies.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-05-09
notable Primary completion pushed: 2027-01-15 -> 2028-01-15 2026-05-09
minor Completion pushed: 2027-06-15 -> 2028-06-15 2026-05-09
Trial Details
NCT Number NCT07388173
Lead Sponsor University Hospital, Grenoble
Conditions Respiratory Infections in Old Age
Enrollment 1,600 participants
Start Date 2026-01-15
Primary Completion 2028-01-15 (estimated)
Study Completion 2028-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-08